Improving patient outcomes through clinical trials

With hundreds of active trials across a broad range of specialties, NBMLHD is helping patients access emerging therapies while driving progress in medical research.

Katherine Carson, Clinical Trials Coordinator at Nepean Cancer and Wellness Centre, says clinical trials are central to improving outcomes for cancer patients.

“Every cancer treatment available today exists because of clinical trials. They give patients access to new and potentially life-saving therapies, particularly when standard treatment options may be limited,” says Katherine.

“Participants are also more closely monitored, with more frequent tests, scans and contact with their care team. That means we can respond quickly to any concerns and provide more personalised care throughout their treatment.”

Peter, a patient at the Nepean Cancer and Wellness Centre, was diagnosed with multiple myeloma in April 2024 after several years of monitoring for a precursor condition known as MGUS.

Following his diagnosis, Peter was invited to participate in the Riddle-M-X clinical trial, a study exploring new and emerging treatment approaches for patients with multiple myeloma.

“When I was offered the chance to join a clinical trial, I saw it as a blessing. I trusted my specialist and believed it would give me the best possible chance,” says Peter.

Peter says his experience on the trial has been overwhelmingly positive, particularly the high level of care and reassurance it has provided.

“The regular and detailed monitoring gives me clarity and peace of mind—I’m not left wondering how things are progressing.”

“The level of support I receive has helped me stay positive and avoid anxiety throughout my treatment,” he says.

Now in ongoing morphological remission, Peter says participating in the trial has not only supported his treatment but also given him a sense of purpose.

“Being part of a clinical trial means I’m contributing to future cancer treatments. If my experience helps someone else down the track, then it’s absolutely worth it.”

The Cancer Clinical Trials team at Nepean Cancer and Wellness Centre conducts a wide range of studies across haematology and oncology, helping to improve how cancer is detected, treated and managed.

Peter’s participation, along with many others, is helping drive advances in cancer care that benefit both current patients and future generations.

“Clinical trials are about more than just treatment—they’re about giving hope and improving lives,” says Katherine.

NBMLHD clinical trials meet strict ethical and scientific standards, ensuring findings can be translated into best practice and routine care.

International Clinical Trials Day is observed each year on 20 May to recognise the vital role that clinical trials play in advancing medical knowledge, improving patient care, and shaping the future of healthcare. At Nepean Blue Mountains Local Health District, this day provides an opportunity to celebrate the contributions of trial participants, researchers, clinicians, coordinators, and support staff, while also raising awareness of the importance of ethical, high quality clinical research and its role in delivering better health outcomes for our communities.